Stock screenerAll disclosures →
EDGAR →
WGRX
Conviction 76HealthcareScan · Mon, Jul 20, 2026WGRX$2.76+4.15%
ResistanceSupportVol 14Vol MA14 19.45K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price2.76
Change+4.15%
Gap+4.15%
Rel volume0.32×
Avg volume21.12K
Avg $ vol62.48K
SMA 202.94
SMA 502.57
SMA 2000.9286
Price vs 50+7.45%
Price vs 200+197.22%
MA stackbullish
50/200 cross—
Supertrendup · 2.61
RSI (14)47
MACD hist-0.08
MACD cross—
Stoch %K / %D30 / 23
ADX (14)21
+DI / −DI19 / 22
RSI divergence—
MACD divergence—
ATR %+9.95%
ADR %8.29%
52w high4.39
52w low0.0788
From 52w high-37.13%
Above 52w low+3402.54%
New 52w highNo
SqueezeOn · 2d
Bollinger width19.22%
%B0.18
Donchian pos27.65%
Donchian high3.48
Donchian low2.48
AVWAP (52w high)3.51
vs AVWAP high-21.40%
AVWAP (52w low)0.1857
vs AVWAP low+1386.32%
OBV trendFlat
Chaikin MF (20)-0.41
Today vs 20d0.32×
Avg vol (14d)19.45K
Avg vol (20d)21.12K
Avg $ vol (20d)62.48K
Market cap346.85M
RS 3m (vs SPY)+1693.12%
RS 6m (vs SPY)+526.76%
RS line new highNo
Trend template7/8
Technical rank77.2
1 week-5.15%
1 month-25.41%
3 months+1816.67%
6 months+575.97%
1 year+200.00%
YTD+536.68%
P/E-3.42
P/B-23.03
P/S14.86
P/FCF—
EPS-1.43
Div yield—
ROE672.36%
ROA-336.15%
Debt/Eq-1.26
Current0.09
EV/EBITDA-4.04
Gross margin-27.54%
Net margin-433.95%
Rev growth28.73%
EPS growth-1377.12%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value365.8M
Revenue1.56M
Net income-7.74M
Gross profit170.22K
Free cash flow—
IndustryWHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
ExchangeNasdaq
Shares out2.51M
Employees—
ListedFri, Feb 21, 2025
Free float55.92M
Float %46.5%
Short interest105.2K
Days to cover3.6d
Short volume22.4%
Squeeze score18 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction76 / 100
Pattern quality—
Tech rank77.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.37
Support2.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in WGRX
No recent disclosed trades by Congress in WGRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in WGRX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
AJJARAPU SURENDRA K Director · Common Stock · 2026-06-22 | Exercise | 100K | $500 | 2026-06-22 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Warrant · 2026-06-22 | Exercise | 100K | — | 2026-06-22 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Common Stock · 2026-06-22 | Exercise | 100K | $500 | 2026-06-22 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Warrant · 2026-06-22 | Exercise | 100K | — | 2026-06-22 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Warrant · 2026-03-31 | Grant | 5M | $500 | 2026-03-31 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Common Stock · 2026-03-31 | Grant | 5M | $1.0M | 2026-03-31 | 2026-06-25 |
Patel Prashant Chief Executive Officer · Warrant · 2026-03-31 | Grant | 5M | $500 | 2026-03-31 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Common Stock · 2026-03-31 | Grant | 5M | $1.0M | 2026-03-31 | 2026-06-25 |
AJJARAPU SURENDRA K Director · Warrant · 2026-03-31 | Grant | 5M | $50K | 2026-03-31 | 2026-04-23 |
Patel Prashant Chief Executive Officer · Warrant · 2026-03-31 | Grant | 5M | $50K | 2026-03-31 | 2026-04-23 |
SEC filings
EDGAR filings in WGRX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.